Login / Signup

Reason and reality-identifying barriers to patient enrolment for clinical trials in invasive candidiasis.

Rosanne SpruteJan-Hendrik GrotheSarah HeringerOliver Andreas Cornely
Published in: The Journal of antimicrobial chemotherapy (2022)
This study identified barriers to enrolment in clinical trials assessing novel antifungal agents in invasive candidiasis. Identification of eligibility criteria associated with non-enrolment allows modification of future trial designs and may ultimately result in higher recruitment rates.
Keyphrases
  • clinical trial
  • candida albicans
  • health insurance
  • phase ii
  • phase iii
  • study protocol
  • open label
  • case report
  • double blind
  • randomized controlled trial
  • current status
  • bioinformatics analysis